Compounds > 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid
Page last updated: 2024-08-26

3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid and nomifensine

3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid has been researched along with nomifensine in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Emre, M; Frey, P; Kelly, PH; Lowe, DA; Malanowski, J; McAllister, KH; Neijt, HC; Rüdeberg, C; Urwyler, S; White, TG1

Other Studies

1 other study(ies) available for 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid and nomifensine

ArticleYear
The pharmacology of SDZ EAA 494, a competitive NMDA antagonist.
    Neurochemistry international, 1994, Volume: 25, Issue:6

    Topics: Animals; Binding Sites; Cats; Corpus Striatum; Dose-Response Relationship, Drug; Electroshock; Kynurenic Acid; Mice; N-Methylaspartate; Nomifensine; Piperazines; Rats; Rats, Sprague-Dawley; Sodium; Spinal Cord

1994